The trial design has two primary objectives ... please visit ClinicalTrials.gov using the identifier NCT05208944. About MAIA Biotechnology, Inc. MAIA is a targeted therapy, immuno-oncology ...

What if business leaders approached strategy the way scientists design gene delivery vectors? In biotechnology, precision, iteration and aligned resources are all critical drivers of breakthroughs ...

PONCHATOULA, La. (WGNO) — It’s a peaceful place for Kathryn Latham – at the easel. With each stroke of her brush, she turns a blank space into a vibrant canvas. She started painting in high ...

Isomorphic will use the windfall to fund development of its next-generation artificial intelligence drug design model, the company announced in a March 31 release. The AI biotech is also looking ...

CHICAGO, March 25, 2025--(BUSINESS WIRE)--MAIA Biotechnology ... predictive biomarker for THIO treatment was selected for poster presentation at the European Lung Cancer Congress 2025 (ELCC ...

MAIA Biotechnology, Inc., (NYSE American ... a potential predictive biomarker for THIO treatment was selected for poster presentation at the European Lung Cancer Congress 2025 (ELCC 2025) taking ...

Since the start of the FIFA World Cup in 1930, it has always been a tradition for FIFA to design an official poster for each edition of the tournament. But for the first time, FIFA World Cup will ...

Expansion study to enroll patients in the U.S. and select countries in Europe and Asia Multiple milestones attainable for 2025 MAIA Biotechnology ... announced the trial design for the expansion ...

Poster to highlight long-term therapeutic benefits of THIO sequenced with cemiplimab beyond treatment cessation CHICAGO--(BUSINESS WIRE)--MAIA Biotechnology, Inc., (NYSE American: MAIA) (“MAIA”, the ...

Oct. 08, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech Inc. (Nasdaq ... today announced upcoming poster presentations on a final report of a Phase 1 dose escalation study and on a preliminary report ...